CRBU - Caribou Bioscience GAAP EPS of -$0.12 beats by $0.30 revenue of $23.66M beats by $20.54M
2023-11-07 17:23:40 ET
More on Caribou Bioscience
- Caribou Biosciences: Antlers Up, Bullish Run In Phase 1 Trials
- Caribou Biosciences, Inc. 2023 Q2 - Results - Earnings Call Presentation
- AbbVie ends Caribou agreement on CAR-T therapy development
- Seeking Alpha’s Quant Rating on Caribou Bioscience
- Historical earnings data for Caribou Bioscience
For further details see:
Caribou Bioscience GAAP EPS of -$0.12 beats by $0.30, revenue of $23.66M beats by $20.54M